MedTrace Logo

Computerized Olfactory Test - Alzheimer Disease Mild Stage

NCT03698760 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2020-07-29

No results posted yet for this study

Summary

This study evaluates the effectiveness of the smell tests that are used in early diagnosis of mild dementia.

Conditions

  • Alzheimer Disease
  • Olfaction Disorders

Interventions

DIAGNOSTIC_TEST

Olfactory test

Olfactory test: All fragrances tested are kept in an airtight case protected from cold and heat. The test is done on a tablet and the data will be automatically saved. The first screen is about the administrative data, sex and age of the subject. Olfactory test: six odors among the fourteen are proposed in a randomized way.

Sponsors & Collaborators

  • Jewish General Hospital

    lead OTHER

Principal Investigators

  • Olivier Beauchet, MD · Jewish General Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-25
Primary Completion
2020-03-05
Completion
2020-03-05

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03698760 on ClinicalTrials.gov